Open access peer-reviewed Edited Volume

Edema

Robson Faria

Oswaldo Cruz Foundation

A researcher in the anti-inflammatory area, a young researcher at FAPERJ and researcher at CNPq level 2, senior researcher in Public Health at FIOCRUZ with 1 registered patent.

Covering

Hemodynamic Disturbance Volume Increase Increase of Fluids Miles Assay Technique Paw Edema Assay Era Edema Assay Collagen Carrageenan ATP Anti-Inflammatory Drugs Diuretic Drugs Corticoids

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

About the book

Edema formation is a hemodynamic disturbance mediated by an increase of fluids in the interstitial space. This process occurs by balancing liquid flow deregulation in the interstitial space and consequent accumulation in body regions, such as members, abdomen, and organs. The liquid retention becomes harmful, affecting cellular metabolism performance due to restricting the exchange of nutrients. In specific organs, the impaired function becomes deleterious to the homeostasis, leading to severe damage. Several factors lead to this phenomenon, such as inflammatory mediators, hormones, plasma proteins, and infectious diseases. Some diseases develop local and generalized edema, as in liver diseases, nephrotic syndrome, lymphedema, and pulmonary edema.

Edema formation and inflammation are directly connected since it is one of the five cardinal signs of the inflammatory process. The inflammatory process is the body's response to pathogens or agents that mediates stress in tissues or organs. During the inflammatory process, cytokines and inflammatory mediators are released, such as IL-1β, TNF-α, IL-6, the vasoactive amines serotonin and histamine, arachidonic acid metabolites, and complement fragments. The edema formation process causes an increase in the permeability of fluids in blood vessels in response to inflammatory mediators activity and subsequent volume increase affecting the tissue, causing pain and swelling. Paw edema assay in murine is standard in vivo assay in trials involving tests of molecules that induce the inflammatory process or inhibition. Mediators as collagen, carrageenan, and ATP are molecules used to promote a pro-inflammatory response. The Miles Assay technique involves edema formation related to the measurement of vascular permeability and cellular mediators. Thus, several intracellular systems are targets for studies involving inflammation, such as the cholinergic system, purinergic system, and intracellular factors, among others. Concerning the studies in this area, they could be investigated in the inflammatory response through the edema analysis.

In clinical practice, the edema condition is still an obstacle related to its pathophysiology and associated diseases. The conventional therapeutic ways for treating edema are generally based on diuretic and anti-inflammatory drugs or in combination with another medicament. However, prolonged use of these drugs may cause side effects on the organism. Diuretic drugs may be harmful to renal homeostasis, and there are cases of patients with resistance to this treatment. These drugs are an aggravating factor in combination with nonsteroidal anti-inflammatory drugs. Nonsteroidal anti-inflammatory drugs prolonged treatment mediates harmful effects to organs, such as the gastrointestinal system, kidney, and heart. Thus, this book intends to provide the reader with a comprehensive overview of the current search for the most effective anti-edema treatment, avoiding the side effects and possible organ overload.

Publishing process

Book initiated and editor appointed

Date completed: November 25th 2020

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline Extended: Open for Submissions

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Approved chapters written in full and submitted

Deadline for full chapters: February 21st 2021

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: May 12th 2021

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: July 11th 2021

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Robson Faria

Oswaldo Cruz Foundation

Robson Faria received his degree in Biological Sciences (2001) from the Federal University of Rio de Janeiro, and M.Sc. (2003) and D.Sc. (2006) from the Oswaldo Cruz Foundation’s Cellular and Molecular Biology program. He has been a Public Health Researcher at the Oswaldo Cruz Foundation since 2007. During the past 15 years, Dr. Robson has been working with the purinergic receptors, especially P2X7R, and the action of synthetic molecules and derivatives of natural products to discover new prototypes capable of treating neglected diseases.

View profile

Book chapters authored 4

Books edited 1

Introducing your Author Service Manager

Mrs. Sara Gojević-Zrnić

As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact.

Ask a question
creativecommons
alpsp
cope
stm
ithenticate
crossref
doi
oaspa

Book will be abstracted and indexed in

googlescholar
worldcat
base
az
openaire